Compared with the PRS developed by Mavaddat et al. (Supplementary Table 9, available online), the updated breast cancer PRS displayed slightly stronger associations in BRCA1 carriers, but no improvements were seen in BRCA2 carriers. This evidence concerns the gene BRCA2 and breast carcinoma.